branchenspezifische Dividenden Summit Therapeutics Inc.
Aktien
A2QDFS
US86627T1088
SMMT
Biotechnologie
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
26,44 USD | -10,31 % | +18,15 % | +939,85 % |
16.09. | Summit Therapeutics meldet hohe Ansprechraten von Ivonescimab-Studien in Krebsstudien | MT |
13.09. | Biontech springen hoch vor 'Esmo'-Kongress | DP |
Zu einer Liste hinzufügen 0 ausgewählt | Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV | Price to Book | EV / Sales | Marktkap. / EBITDA | Marktkap. / EBIT | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|
-.--% | -.--% | -246.97x | 7,695 | 10.83x | 142.55x | 193.03x | 126 Mrd. | ||
-.--% | -.--% | 30.95x | 4,258 | 8.14x | 19.84x | 21.77x | 124 Mrd. | ||
-.--% | -.--% | -527.02x | 7,369 | 14.5x | -176.06x | -166.91x | 32,29 Mrd. | ||
-.--% | -.--% | -46.31x | 1,354 | 5.15x | -14.58x | -11.68x | 29,36 Mrd. | ||
-.--% | -.--% | -32.26x | 6,266 | 5.3x | -32.57x | -26.98x | 20,89 Mrd. | ||
-.--% | -.--% | 21.53x | 3,399 | 4.24x | 13.89x | 14.58x | 16,82 Mrd. | ||
+2,42% | +2,64% | 12.13x | 1,883 | 2.65x | 7.52x | 9.04x | 16,04 Mrd. | ||
-.--% | -.--% | -25.49x | - | - | - | - | 14,13 Mrd. | ||
-.--% | -.--% | -14.09x | -57,174300 | 36.79x | -17.16x | -16.6x | 12,58 Mrd. | ||
-.--% | -.--% | 28.58x | 4,368 | 4.47x | 16.53x | 16.8x | 12,34 Mrd. | ||
-.--% | -.--% | 66.97x | 9,459 | 6.39x | 77.94x | 153.56x | 11,86 Mrd. | ||
-.--% | -.--% | -81.04x | 6,670 | 120.01x | -86.23x | -69.39x | 9,68 Mrd. | ||
-.--% | -.--% | -43.53x | 9,873 | 15.33x | -30.19x | -26.54x | 9,39 Mrd. | ||
-.--% | -.--% | 17.71x | 3,247 | 3.31x | 11.89x | 13.16x | 7,84 Mrd. | ||
+0,14% | +0,30% | 69.18x | 8,457 | 21.96x | 159.05x | 117.59x | 7,24 Mrd. | ||
-.--% | -.--% | -152.11x | 11,84 | 22.47x | -368.38x | -146.93x | 7,95 Mrd. | ||
Durchschnitt | +0,16 % | +0,18 % | -57,61x | 1,93 | 18,77x | -18,40x | 4,97x | 28,7 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | +0,09 % | +0,10 % | -102,34x | 4,01 | 12,33x | 27,29x | 49,15x |
- Börse
- Aktien
- A2QDFS Aktie
- Sektor Summit Therapeutics Inc.
- branchenspezifische Dividenden
MarketScreener is also available in this country: United States.
Switch edition